Physician profile
Mallory Jo Brooks
NPI 1467051151
$277.95
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $118 · 2023: $57.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $37.26 | 2022-2023 | |
| Corium, LLC | $24.39 | 2023 | Azstarys |
| Dexcom, INC. | $21.30 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.92 | 2021 | |
| Glaxosmithkline, LLC. | $18.66 | 2023 | Pediarix, Bexsero |
| Regeneron Healthcare Solutions, INC. | $17.91 | 2022 | |
| Amgen INC. | $17.25 | 2022 | |
| Genzyme Corporation | $15.29 | 2021 | |
| Advanced Respiratory, INC | $14.79 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $14.13 | 2022 | |
| United Therapeutics Corporation | $14.08 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.02 | 2021 | |
| Amarin Pharma, INC. | $12.72 | 2021 | |
| Insulet Corporation | $12.50 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.